Application Cycle
February 2024
The team aims to develop a molecule that inhibits bacterial movement during UTI infection, thus preventing bacteria from escaping antibiotics and forming recurrent infections. This strategy could significantly reduce recurrent, resistant infections, particularly in UTIs.
Awardee
Department